Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study-Reference-Cited by-同舟云学术

Pemetrexed in Second Line and beyond Small Cell Lung Cancer: A Hoosier Oncology Group Phase II Study

Published:2009-01 Issue:1 Volume:4 Page:93-96
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Jalal Shadia,Ansari Rafat,Govindan Ramaswamy,Bhatia Sumeet,Bruetman Daniel,Fisher William,Masters Gregory,White Angela,Stover Daniel,Yu Menggang,Hanna Nasser

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference17 articles.

1. Changing epidemiology of small cell lung cancer in the United States over the past three decades: analysis of surveillance, epidemiologic and end results database;Govindan;J Clin Oncol,2006

2. Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress;Chute;J Clin Oncol,1999

3. Survival benefit of oral topotecan plus supportive care versus supportive care alone in relapsed, resistant SCLC;O'Brien;Lung Cancer,2005

4. Chemotherapy of lung cancer;Morrison,1992

5. A phase II study of 5-fluorouracil plus high-dose folinic acid in the treatment of recurrent small cell lung cancer;Stewart;Am J Clin Oncol,1995

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Large Cell Neuro-Endocrine Carcinoma of the Lung: Current Treatment Options and Potential Future Opportunities;Frontiers in Oncology;2021-04-15

2. Anti-PD-L1 immune checkpoint inhibitors in combination with etoposide and platinum for extensive-stage small cell lung cancer: a case report;Annals of Palliative Medicine;2021-01

3. A phase II study of pembrolizumab and paclitaxel in patients with relapsed or refractory small-cell lung cancer;Lung Cancer;2019-10

4. Treatment advances in small cell lung cancer (SCLC);Pharmacology & Therapeutics;2017-12

5. Second-line treatments of small-cell lung cancers;Expert Review of Anticancer Therapy;2017-09-08